Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide And Tirzepatide

A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

Eli Lilly · Phase 1 · Completed · Enrollment 188

NCT06916065

ArmPopulationDoseWeeksEstimandWeight change
Eloralintide and Tirzepatide-Cohorts A-DObesity or overweightn/r26n/rn/r
Eloralintide-Cohorts E and FObesity or overweightn/r26n/rn/r